Page last updated: 2024-08-24

telmisartan and Hyperlipemia

telmisartan has been researched along with Hyperlipemia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barkhausen, J; Hübel, N; Mildner, M; Müller-Fielitz, H; Raasch, W; Vogt, FM1
Chan, JC; Chan, TY; Fok, BS; Ho, CS; Hu, M; Lee, HK; To, KK; Tomlinson, B; Wo, SK; Wong, CK; Zuo, Z1
Elisaf, MS; Florentin, M; Kostapanos, MS; Kostara, CE; Liberopoulos, EN; Milionis, HJ; Rizos, CV1
Asgari, AA; Sarvghadi, F; Zahed, N1
Grossman, E; Harari, A; Harats, D; Kamari, Y; Peleg, E; Shaish, A; Sharabi, Y1
Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Muragaki, Y; Shiomi, M; Tsujioka, H; Yoshida, K1

Trials

2 trial(s) available for telmisartan and Hyperlipemia

ArticleYear
Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:12

    Topics: Adult; Aged; Animals; Antihypertensive Agents; Area Under Curve; Asian People; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzimidazoles; Benzoates; Biological Transport; Dogs; Drug Interactions; Genotype; Healthy Volunteers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Madin Darby Canine Kidney Cells; Male; Middle Aged; Neoplasm Proteins; Rosuvastatin Calcium; Telmisartan; White People

2016
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Clinical therapeutics, 2010, Volume: 32, Issue:3

    Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; C-Reactive Protein; Drug Therapy, Combination; Fasting; Female; Fluorobenzenes; Greece; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Imidazoles; Insulin; Irbesartan; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Telmisartan; Tetrazoles

2010

Other Studies

4 other study(ies) available for telmisartan and Hyperlipemia

ArticleYear
Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.
    British journal of pharmacology, 2014, Volume: 171, Issue:3

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Antihypertensive Agents; Behavior, Animal; Benzimidazoles; Benzoates; Diet, High-Fat; Dietary Sucrose; Drug Therapy, Combination; Energy Intake; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain

2014
Telmisartan vs. enalapril in type 2 diabetes.
    The New England journal of medicine, 2005, Feb-24, Volume: 352, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Diabetic Nephropathies; Enalapril; Humans; Hyperlipidemias; Risk Factors; Telmisartan

2005
Effect of telmisartan, angiotensin II receptor antagonist, on metabolic profile in fructose-induced hypertensive, hyperinsulinemic, hyperlipidemic rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:1

    Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diet; Fructose; Hyperinsulinism; Hyperlipidemias; Hypertension; Insulin; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Telmisartan; Triglycerides

2008
Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
    Journal of hypertension, 2008, Volume: 26, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Aorta, Abdominal; Aorta, Thoracic; Atherosclerosis; Benzimidazoles; Benzoates; Biphenyl Compounds; Disease Models, Animal; Hyperlipidemias; Male; Nitric Oxide; PPAR gamma; Rabbits; Telmisartan; Tetrazoles; Up-Regulation

2008